Hoffner B - Search Results

1

Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer.

Hamid O, Hoffner B, Gasal E, Hong J, Carvajal RD. Hamid O, et al. Among authors: hoffner b. Cancer Immunol Immunother. 2017 Oct;66(10):1249-1264. doi: 10.1007/s00262-017-2025-8. Epub 2017 Jul 15. Cancer Immunol Immunother. 2017. PMID: 28712033 Free PMC article. Review.

2

Administration and Handling of Talimogene Laherparepvec: An Intralesional Oncolytic Immunotherapy for Melanoma.

Hoffner B, Iodice GM, Gasal E. Hoffner B, et al. Oncol Nurs Forum. 2016 Mar;43(2):219-26. doi: 10.1188/16.ONF.219-226. Oncol Nurs Forum. 2016. PMID: 26906132

3

Programmed death 1 immune checkpoint inhibitors.

Trivedi MS, Hoffner B, Winkelmann JL, Abbott ME, Hamid O, Carvajal RD. Trivedi MS, et al. Among authors: hoffner b. Clin Adv Hematol Oncol. 2015 Dec;13(12):858-68. Clin Adv Hematol Oncol. 2015. PMID: 27058852 Review.

4

Hepatic hemorrhage as a consequence of rapid response to combined targeted therapy in metastatic melanoma.

Flaherty DC, Hoffner BW, Lau BJ, Hamid O, Faries MB. Flaherty DC, et al. Among authors: hoffner bw. J Surg Oncol. 2015 Dec;112(8):844-5. doi: 10.1002/jso.24078. Epub 2015 Oct 26. J Surg Oncol. 2015. PMID: 26503563 Free PMC article.

5

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.

Ribas A, Hamid O, Daud A, Hodi FS, Wolchok JD, Kefford R, Joshua AM, Patnaik A, Hwu WJ, Weber JS, Gangadhar TC, Hersey P, Dronca R, Joseph RW, Zarour H, Chmielowski B, Lawrence DP, Algazi A, Rizvi NA, Hoffner B, Mateus C, Gergich K, Lindia JA, Giannotti M, Li XN, Ebbinghaus S, Kang SP, Robert C. Ribas A, et al. Among authors: hoffner b. JAMA. 2016 Apr 19;315(15):1600-9. doi: 10.1001/jama.2016.4059. JAMA. 2016. PMID: 27092830 Clinical Trial.

6

We can study ultrarare tumors effectively in this day and age, it just takes a cooperative approach: The role of dasatinib in assorted indolent sarcomas.

Villalobos VM, Hoffner B, Elias AD. Villalobos VM, et al. Among authors: hoffner b. Cancer. 2017 Jan 1;123(1):20-24. doi: 10.1002/cncr.30377. Epub 2016 Oct 3. Cancer. 2017. PMID: 27696384 Free PMC article.

7

Targeted Therapies in the Treatment of Sarcomas.

Hoffner B, Elias AD, Villalobos VM. Hoffner B, et al. Target Oncol. 2018 Oct;13(5):557-565. doi: 10.1007/s11523-018-0583-0. Target Oncol. 2018. PMID: 30143942 Review.

8

Trametinib: A Targeted Therapy in Metastatic Melanoma.

Hoffner B, Benchich K. Hoffner B, et al. J Adv Pract Oncol. 2018 Nov-Dec;9(7):741-745. Epub 2018 Nov 1. J Adv Pract Oncol. 2018. PMID: 31249721 Free PMC article. Review.

9

Ipilimumab-Based  Therapy: Consensus Statement From the Faculty of the Melanoma Nursing Initiative on Managing Adverse Events With Ipilimumab Monotherapy and Combination Therapy With Nivolumab.

Madden KM, Hoffner B. Madden KM, et al. Among authors: hoffner b. Clin J Oncol Nurs. 2017 Aug 1;21(4 Suppl):30-41. doi: 10.1188/17.CJON.S4.30-41. Clin J Oncol Nurs. 2017. PMID: 28738054 Free article.

10

Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancer.

Hoffner B, Leighl NB, Davies M. Hoffner B, et al. Cancer Treat Rev. 2020 Apr;85:101979. doi: 10.1016/j.ctrv.2020.101979. Epub 2020 Feb 4. Cancer Treat Rev. 2020. PMID: 32078962 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page